Urinary tract infections of Escherichia coli strains of chaperone-usher system

Polish Journal of Microbiology

Volumn 60, Issue 4, 2011, Pages 279-285

  Zalewska Pia̧tek, Beata M ^a  

^a GDANSK UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Chaperone usher; Cystitis; Pyelonephritis; Uropathogenic E. Coli

Indexed keywords

CYTOKINE; POLYMER; VACCINE; VIRULENCE FACTOR;

ADULT RESPIRATORY DISTRESS SYNDROME; BACTERIAL INFECTION; BACTERIAL SECRETION SYSTEM; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BIOFILM; CYSTITIS; DEATH; DIARRHEA; GRAM NEGATIVE BACTERIUM; HUMAN; INFECTION RISK; NONHUMAN; PYELONEPHRITIS; RECURRENT DISEASE; SHORT SURVEY; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI; UROSEPSIS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; NEGIBACTERIA;

EID: 84855663326     PISSN: 17331331     EISSN: None     Source Type: Journal    
DOI: 10.33073/pjm-2011-040     Document Type: Short Survey

References (103)

1. Anderson K.L., J. Billington, D. Pettigrew, E. Cota, P. Simpson, P. Roversi, H.A. Chen, P. Urvil, L. du Merle, P.N. Barlow and others. 2004. An atomic resolution model for assembly, architecture, and function of the Dr adhesins. Mol. Cell 15: 647-657. (Pubitemid 39141790)
2. Arisoy M., D. Aysev, M. Ekim, D. Ozel, S.K. Köse, E.D. Ozsoy and N. Akar. 2006. Detection of virulence factors of Escherichia coli from children by multiplex polymerase chain reaction. Int. J. Clin. Pract. 60: 170-173. (Pubitemid 43740496)
3. Avorn J., M. Monane, J.H. Gurwitz, R.J. Glynn, I. Choodnovskiy and L.A. Lipsitz. 1994. Reduction of bacteriuria and pyuria after ingestion of cranberry juice. JAMA. 271: 751-754. (Pubitemid 24074521)
4. Bahrani-Mougeot F.K., E.L. Buckles, C.V. Lockatell, J.R. Hebel, D.E. Johnson, C.M. Tang and M.S. Donnenberg. 2002. Type 1 fimbriae and extracellular polysaccharides are preeminent uropathogenic Escherichia coli virulence determinants in the murine urinary tract. Mol. Microbiol. 45: 1079-1093. (Pubitemid 35007450)
5. Barnhart M.M., J.S. Pinkner, G.E. Soto, F.G. Sauer, S. Langermann, G. Waksman, C. Frieden and S.J. Hultgren. PapD-like chaperones provide the missing information for folding of pilin proteins. Proc. Natl. Acad. Sci. USA. 97: 7709-7714.
6. Berger C.N., O. Billker, T.F. Meyer, A.L. Servin and I. Kansau. 2004. Differential recognition of members of the carcinoembryonic antigen family by Afa/Dr adhesins of diffusely adhering Escherichia coli (Afa/Dr DAEC). Mol. Microbiol. 52: 963-983. (Pubitemid 38916168)
7. Blum G., M. Ott, A. Lischewski, A. Ritter, H. Imrich, H. Tschäpe and J. Hacker. 1994. Excision of large DNA regions termed pathogenicity islands from tRNA-specific loci in the chromosome of an Escherichia coli wild-type pathogen. Infect. Immun. 62: 606-614. (Pubitemid 24033781)
8. Bouckaert J., J. Berglund, M. Schembri, E. De Genst, L. Cools, M. Wuhrer, C.S. Hung, J. Pinkner, R. Slättegård, A. Zavialov and others. 2005. Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin. Mol. Microbiol. 55: 441-455. (Pubitemid 40179379)
9. Braun V., K. Hantke and W. Köster. 1998. Bacterial iron transport: mechanisms, genetics, and regulation. Met. Ions Biol. Syst. 35: 67-145.
10. Capitani G., O. Eidam, R. Glockshuber and M.G. Grütter. 2006a. Structural and functional insights into the assembly of type 1 pili from Escherichia coli. Microbes Infect. 8: 2284-2290. (Pubitemid 44311597)
11. Capitani G., O. Eidam and M.G. Grütter. 2006b. Evidence for a novel domain of bacterial outer membrane ushers. Proteins 65: 816-823. (Pubitemid 44772881)
12. Caprioli A., V. Falbo, F.M. Ruggeri, L. Baldassarri, R. Bisicchia, G. Ippolito, E. Romoli and G. Donelli. 1987. Cytotoxic necrotizing factor production by hemolytic strains of Escherichia coli causing extraintestinal infections. J. Clin. Microbiol. 25: 146-149. (Pubitemid 17202994)
13. Carnoy C. and S.L. Moseley. 1997. Mutational analysis of receptor binding mediated by the Dr family of Escherichia coli adhesins. Mol. Microbiol. 23: 365-379. (Pubitemid 27049189)
14. Chorell E., J.S. Pinkner, G. Phan, S. Edvinsson, F. Buelens, H. Remaut, G. Waksman, S.J. Hultgren and F. Almqvist. 2010. Design and synthesis of C-2 substituted thiazolo and dihydrothiazolo ring-fused 2-pyridones: pilicides with increased antivirulence activity. J. Med. Chem. 53: 5690-5695.
15. Connell I., W. Agace, P. Klemm, M. Schembri, S. Mǎ;rild and C. Svanborg. 1996. Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. Proc. Natl. Acad. Sci. USA. 93: 9827-9832. (Pubitemid 26296694)
16. Cunningham F.G. and M.J. Lucas. 1994. Urinary tract infections complicating pregnancy. Baillieres Clin. Obstet. Gynaecol. 8: 353-373. (Pubitemid 24200812)
17. Di Martino P., R. Agniel, K. David, C. Templer, J.L. Gaillard, P. Denys and H. Botto. 2006. Reduction of Escherichia coli adherence to uroepithelial bladder cells a\er consumption of cranberry juice: a double-blind randomized placebo-controlled cross-over trial. World J. Urol. 4: 21-27. (Pubitemid 43298679)
18. Emödy L., M. Kerényi and G. Nagy. 2003. Virulence factors of uropathogenic Escherichia coli. Int. J. Antimicrob. Agents. 2: 29-33.
19. Fiorentini C., A. Fabbri, P. Matarrese, L. Falzano, P. Boquet and W. Malorni. 1997. Hinderance of apoptosis and phagocytic behaviour induced by Escherichia coli cytotoxic necrotizing factor #1: two related activities in epithelial cells. Biochem. Biophys. Res. Commun. 241: 341-346. (Pubitemid 28020103)
20. Firon N., S. Ashkenazi, D. Mirelman, I. Ofek and N. Sharon. 1987. Aromatic alpha-glycosides of mannose are powerful inhibitors of the adherence of type 1 fimbriated Escherichia coli to yeast and intestinal epithelial cells. Infect. Immun. 55: 472-476. (Pubitemid 17004131)
21. Foxman B., L. Zhang, P. Tallman, K. Palin, C. Rode, C. Bloch, B. Gillespie and C.F. Marrs. 1995. Virulence characteristics of Esche richia coli causing first urinary tract infection predict risk of second infection. J. Infect. Dis. 172: 1536-1541.
22. Foxman B. 2002. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am. J. Med. 113 Suppl. 1A: 5S-13S. (Pubitemid 34756640)
23. Foxman B. 2003a. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis. Mon. 49: 53-70. (Pubitemid 36350775)
24. Foxman B. and P. Brown. 2003b. Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infect. Dis. Clin. North. Am. 17: 227-241. (Pubitemid 36760181)
25. Goluszko P., S.L. Moseley, L.D. Truong, A. Kaul, J.R. Williford, R. Selvarangan, S. Nowicki and B. Nowicki. 1997. Development of experimental model of chronic pyelonephritis with Escherichia coli O75:K5:H-bearing Dr fimbriae: mutation in the dra region prevented tubulointerstitial nephritis. J. Clin. Invest. 99: 1662-1672. (Pubitemid 27163817)
26. Goluszko P., R. Selvarangan, V. Popov, T. Pham, J.W. Wen and J. Singhal. 1999. Decay-accelerating factor and cytoskeleton redistribution pattern in HeLa cells infected with recombinant Escherichia coli strains expressing Dr family of adhesins. Infect. Immun. 67: 3989-3997. (Pubitemid 29357019)
27. Guerinot M.L. 1994. Microbial iron transport. Annu. Rev. Microbiol. 48: 743-772. (Pubitemid 24334115)
28. Guignot J., S. Hudault, I. Kansau, I. Chau and A.L. Servin. 2009. DAF and CEACAMs receptor-mediated internalization and lifestyle of Afa/Dr diffusely adhering Escherichia coli into epithelial cells. Infect. Immun. 77: 517-531.
29. Gupta K. 2003. Emerging antibiotic resistance in urinary tract pathogens. Infect. Dis. Clin. North. Am. 17: 243-259. (Pubitemid 36760182)
30. Gutierrez K. 1996. Continuation of antibiotic therapy for serious bacterial infections outside of the hospital. Pediatr. Ann. 25: 639-645.
31. Guyer D.M., S. Radulovic, F.E. Jones and H.L. Mobley. 2002. Sat, the secreted autotransporter toxin of uropathogenic Escherichia coli, is a vacuolating cytotoxin for bladder and kidney epithelial cells. Infect. Immun. 70: 4539-4546. (Pubitemid 34790966)
32. Hedenström M., H. Emtenäs, N. Pemberton, V. Aberg, S.J. Hultgren, J.S. Pinkner, V. Tegman, F. Almqvist, I. Sethson and J. Kihlberg. 2005. NMR studies of interactions between periplasmic chaperones from uropathogenic E. coli and pilicides that interfere with chaperone function and pilus assembly. Org. Biomol. Chem. 3: 4193-4200. (Pubitemid 41801590)
33. Hacker J. and J.B. Kaper. 2000. Pathogenicity islands and the evolution of microbes. Annu. Rev. Microbiol. 54: 641-679.
34. Hooton T. M. 2001. Recurrent urinary tract infection in women. Int. J. Antimicrob. Agents. 17: 259-268. (Pubitemid 32288741)
35. Hooton T.M. and S.B. Levy. 2001. Antimicrobial resistance: a plan of action for community practice. Am. Fam. Physician. 63: 1087-1098.
36. Hung D.L., S.D. Knight, R.M. Woods, J.S. Pinkner and S.J. Hultgren. 1996. Molecular basis of two subfamilies of immunoglobulinlike chaperones. EMBO J. 15: 3792-3805. (Pubitemid 26289789)
37. Johnson J.R. and M. Kuskowski. 2000. Clonal origin, virulence factors, and virulence. Infect. Immun. 68: 424-425.
38. Johnson J.R. 2003. Microbial virulence determinants and the pathogenesis of urinary tract infection. Infect. Dis. Clin. North. Am. 17: 261-278. (Pubitemid 36760183)
39. Källenius G., R. Möllby, S.B. Svenson, I. Helin, H. Hultberg, B. Cedergren and J. Winberg. 1981. Occurrence of P-fimbriated Escherichia coli in urinary tract infections. Lancet. 2: 1369-1372. (Pubitemid 12239441)
40. Keane W.F., R. Welch, G. Gekker and P.K. Peterson. 1987. Mechanism of Escherichia coli alpha-hemolysin-induced injury to isolated renal tubular cells. Am. J. Pathol. 126: 350-357. (Pubitemid 17033860)
41. Knight S.D., J. Berglund and D. Choudhury. 2000. Bacterial adhesins: structural studies reveal chaperone function and pilus biogenesis. Curr. Opin. Chem. Biol. 4: 653-660.
42. Kontiokari T., K. Sundqvist, M. Nuutinen, T. Pokka, M. Koskela and M. Uhari. 2001. Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ. 322:1571.
43. Korotkova N., Y. Yang, I. Le Trong, E. Cota, B. Demeler, J. Marchant, W.E. 'omas, R.E. Stenkamp, S.L. Moseley and S. Matthews. 2008a. Binding of Dr adhesins of Escherichia coli to carcinoem bryonic antigen triggers receptor disssociation. Mol. Microbiol. 67: 420-434. (Pubitemid 350295843)
44. Korotkova N., Y. Yarova-Yarovaya, V. Tchesnokova, N. Yazvenko, M.A. Carl, A.E. Stapleton and S.L. Moseley. 2008b. Escherichia coli DraE adhesin-associated bacterial internalization by epithelial cells is promoted independently by decay-accelerating factor and carcinoembryonic antigen-related cell adhesion molecule binding and does not require the DraD invasin. Infect. Immun. 76: 3869-3880.
45. Labigne-Roussel A. and S. Falkow. 1988. Distribution and degree of heterogeneity of the a]mbrial-adhesin-encoding operon (afa) among uropathogenic Escherichia coli isolates. Infect. Immun. 56: 640-648.
46. Langermann S., R. Möllby, J.E. Burlein, S.R. Palaszynski, C.G. Auguste, A. DeFusco, R. Strouse, M.A. Schenerman, S.J. Hultgren, J.S. Pinkner and others. 2000. Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli. J. Infect. Dis. 181: 774-778.
47. Langermann S. and W.R. Jr Ballou. 2001. Vaccination utilizing the FimCH complex as a strategy to prevent Escherichia coli urinary tract infections. J. Infect. Dis. 183 Suppl 1: S84-S86. (Pubitemid 32174156)
48. Le Bouguénec C. and A.L. Servin. 2006. Diffusely adherent Escherichia coli strains expressing Afa/Dr adhesins (Afa/Dr DAEC): hitherto unrecognized pathogens. FEMS Microbiol. Lett. 256: 185-194. (Pubitemid 43356788)
49. Lewczyk E. and S. Jankowski. 2003. Urinary tract infections in children (in Polish). Adv. Clin. Exp. Med. 12: 375-380. (Pubitemid 36665769)
50. Lund B., F. Lindberg, B.I. Marklund and S. Normark. 1987. The PapG protein is the alpha-D-galactopyranosyl-(1→4)-beta-Dgalactopyranose-binding adhesin of uropathogenic Escherichia coli. Proc. Natl. Acad. Sci. USA. 84: 5898-5902.
51. Millar L.K. and S. M. Cox. 1997. Urinary tract infections complicating pregnancy. Infect. Dis. Clin. North. Am. 11: 13-26. (Pubitemid 27182268)
52. Morrisom D.C. and J.L. Ryan. 1987. Endotoxins and disease mechanisms. Annu. Rev. Med. 38: 417-432.
53. Mulvey M.A., Y.S. Lopez-Boado, C.L. Wilson, R. Roth, W.C. Parks, J. Heuser and S.J. Hultgren. 1998. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science. 282: 1494-1497. (Pubitemid 28538612)
54. Nishiyama M., R. Horst, O. Eidam, T. Herrmann, O. Ignatov, M. Vetsch, P. Bettendor(, I. Jelesarov, M.G. Grütter, K. Wüthrich and others. 2005. Structural basis of chaperone-subunit complex recognition by the type 1 pilus assembly platform FimD. EMBO J. 24: 2075-2086. (Pubitemid 40961792)
55. Nowicki B., J. Moulds, R. Hull and S. Hull. 1988. A hemagglutinin of uropathogenic Escherichia coli recognizes the Dr blood group antigen. Infect. Immun. 56: 1057-1060.
56. Nowicki B., M. Martens, A. Hart and S. Nowicki. 1994. Gestational age-dependent distribution of Escherichia coli fimbriae in pregnant patients with pyelonephritis. Ann. NY Acad. Sci. 730: 290-91. (Pubitemid 24292230)
57. Nowicki B., R. Selvarangan and S. Nowicki. 2001. Family of Escherichia coli Dr adhesins: decay-accelerating factor receptor recognition and invasiveness. J. Infect. Dis. Suppl 1 183: S24-27. (Pubitemid 32174141)
58. Oelschlaeger T.A., U. Dobrindt and J. Hacker. 2002. Pathogenicity islands of uropathogenic E. coli and the evolution of virulence. Int. J. Antimicrob. Agents. 19: 517-521. (Pubitemid 34831657)
59. Ofek I., D.L. Hasty and N. Sharon. 2003. Anti-adhesion therapy of bacterial diseases: prospects and problems. FEMS Immunol. Med. Microbiol. 38: 181-191. (Pubitemid 37289742)
60. Ohlsson J., J. Jass, B.E. Uhlin, J. Kihlberg and U.J. Nilsson. 2002. Discovery of potent inhibitors of PapG adhesins from uropathogenic Escherichia coli through synthesis and evaluation of galabiose derivatives. Chembiochem. 3: 772-779. (Pubitemid 36004517)
61. Pia̧tek R., B. Zalewska, O. Kolaj, M. Ferens, B. Nowicki and J. Kur. 2005a. Molecular aspects of biogenesis of Escherichia coli Dr fimbriae: characterization of DraB-DraE complexes. Infect. Immun. 73: 135-145. (Pubitemid 40041103)
62. Pia̧tek R., B. Zalewska, K. Bury and J. Kur. 2005b. The chaperoneusher pathway of bacterial adhesin biogenesis - from molecular mechanism to strategies of anti-bacterial prevention and modern vaccine design. Acta Biochim. Pol. 52: 639-46. (Pubitemid 41571709)
63. Picard B., J.S. Garcia, S. Gouriou, P. Duriez, N. Brahimi, E. Bingen, J. Elion and E. Denamur. 1999. The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect. Immun. 67: 546-553. (Pubitemid 29059185)
64. Pinkner J.S., H. Remaut, F. Buelens, E. Miller, V. Aberg, N. Pemberton, M. Hendenström, A. Larsson, P. Seed, G. Waksaman and others. 2006. Rationally designed small compounds inhibit pilus biogenesis in uropathogenic bacteria. Proc. Natl. Acad. Sci. USA. 103: 17897-17902. (Pubitemid 44852257)
65. Pettigrew D., K.L. Anderson, J. Billington, E. Cota, P. Simpson, P. Urvil, F. Rabuzin, P. Roversi, B. Nowicki, L. du Merle and others. 2004. High resolution studies of the Afa/Dr adhesin DraE and its interaction with chloramphenicol. J. Biol. Chem. 279: 46851-46857. (Pubitemid 39518336)
66. Remaut H., R.J. Rose, T.J. Hannan, S.J. Hultgren, S.E. Radford, A.E. Ashcroft and G. Waksman. 2006. Donor-strand exchange in chaperone-assisted pilus assembly proceeds through a concerted beta strand displacement mechanism. Mol. Cell. 22: 831-842.
67. Rietschel E.T., H. Brade, O. Holst, L. Brade, S. Müller-Loennies, U. Mamat, U. Zähringer, F. Beckmann, U. Seydel, K. Brandenburg and others. 1996. Bacterial endotoxin: chemical constitution, biological recognition, host response, and immunological detoxification. Curr. Top Microbiol. Immunol. 216: 39-81. (Pubitemid 28012915)
68. Roberts J.A., B.I. Marklund, D. Ilver, D. Haslam, M.B. Kaack, G. Baskin, M. Louis, R. Möllby, J. Winberg and S. Normark. 1994. The Gal(alpha 1-4)Gal-specific tip adhesin of Escherichia coli P-fimbriae is needed for pyelonephritis to occur in the normal urinary tract. Proc. Natl. Acad. Sci. USA. 91: 11889-11893. (Pubitemid 24368569)
69. Ronald A. 2002. The etiology of urinary tract infection: traditional and emerging pathogens. Am. J. Med. 113 Suppl 1A: 14S-19S. (Pubitemid 34756641)
70. Selvarangan R., P. Goluszko, J. Singhal, C. Carnoy, S. Moseley, B. Hudson, S. Nowicki and B. Nowicki. 2004. Interaction of Dr adhesin with collagen type IV i s a critical step in Escherichia coli renal persistence. Infect. Immun. 72: 4827-4835. (Pubitemid 38989343)
71. Saulino E.T., E. Bullitt and S.J. Hultgren. 2000. Snapshots of usher-mediated protein secretion and ordered pilus assembly. Proc. Natl. Acad. Sci.USA. 97: 9240-9245. (Pubitemid 30626703)
72. Sauer F.G., K. Futterer, J.S. Pinkner, K.W. Dodson, S.J. Hultgren and G. Waksman. 1999. Structural basis of chaperone function and pilus biogenesis. Science 285: 1058-1061.
73. Sauer F.G., M. Barnhart, D. Choudhury, S.D. Knight, G. Waksman and S.J. Hultgren. 2000. Chaperone-assisted pilus assembly and bacterial attachment. Curr. Opin Struct Biol. 10: 548-556.
74. Sauer F.G., H. Remaut, S.J. Hultgren and G. Waksman. 2004. Fiber assembly by the chaperone-usher pathway. Biochim. Biophys. Acta. 1694: 259-267. (Pubitemid 39535073)
75. Schubert S., B. Picard, S. Gouriou, J. Heesemann and E. Denamur. 2002. Yersinia high-pathogenicity island contributes to virulence in Escherichia coli causing extraintestinal infections. Infect. Immun. 70: 5335-5337.
76. Servin A.L. 2005. Pathogenesis of Afa/Dr diffusely adhering Escherichia coli. Int. J. Med. Microbiol. 295: 471-478.
77. Selvarangan R., P. Goluszko, J. Singhal, C. Carnoy, S. Moseley, B. Hudson, S. Nowicki and B. Nowicki. 2004. Interaction of Dr adhesin with collagen type IV is a critical step in Escherichia coli renal persistence. Infect. Immun. 72: 4827-4835. (Pubitemid 38989343)
78. Smith H.W. 1963. The haemolysins of Escherichia coli. J. Pathol. Bacteriol. 85: 197-211.
79. Sobotová D. 2011. Urinary tract infections and chronic renal failure. Vnitr. Lek. 57: 626-630.
80. Sokurenko E.V., V. Chesnokova, R.J. Doyle and D.L. Hasty. 1997. Diversity of the Escherichia coli type 1 fimbrial lectin. Differential binding to mannosides and uroepithelial cells. J. Biol. Chem. 272: 17880-17886. (Pubitemid 27311232)
81. Stamm W.E. and T.M. Hooton. 1993. Management of urinary tract infections in adults. N. Engl. J. Med. 329: 1328-1334. (Pubitemid 23317334)
82. Striker R., U. Nilsson, A. Stonecipher, G. Magnusson and S.J. Hultgren. 1995. Structural requirements for the glycolipid receptor of human uropathogenic Escherichia coli. 6: 1021-1029.
83. Strömberg N., B.I. Marklund, B. Lund, D. Ilver, A. Hamers, W. Gaas tra, K.A. Karlsson and S. Normark. 1990. Host-specificity of uropathogenic Escherichia coli depends on differences in binding speci]city to Gal alpha 1-4Gal-containing isoreceptors. EMBO J. 9: 2001-2010.
84. Strömberg N., P.G. Nyholm, I. Pascher and S. Normark. 1991. Saccharide orientation at the cell surface affects glycolipid receptor function. Proc. Natl. Acad. Sci. USA. 88: 9340-9344. (Pubitemid 21915627)
85. Svensson A., A. Larsson, H. Emtenäs, M. Hedenström, T. Fex, S.J. Hultgren, J.S. Pinkner, F. Almqvist and J. Kihlberg. 2001. Design and evaluation of pilicides: potential novel antibacterial agents directed against uropathogenic Escherichia coli. Chembiochem. 2: 915-918. (Pubitemid 33722705)
86. Thanassi D.G., E.T. Saulino and S.J. Hultgren. 1998. The chaperone/usher pathway: a major terminal branch of the general secretory pathway. Curr. Opin. Microbiol. 1: 223-231. (Pubitemid 128428064)
87. Thanassi D.G., C. Stathopoulos, K. Dodson, D. Geiger and S.J. Hultgren. 2002. Bacterial outer membrane ushers contain distinct targeting and assembly domains for pilus biogenesis. J. Bacteriol. 184: 6260-6269. (Pubitemid 35265907)
88. Thankavel K., B. Madison, T. Ikeda, R. Malaviya, A.H. Shah, P.M. Arumugam and S.N. Abraham. 1997. Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection. Clin. Invest. 100: 1123-3116.
89. Torres A.G. and S.M. Payne. 1997. Haem iron-transport system in enterohaemorrhagic Escherichia coli O157:H7. Mol. Microbiol. 23: 825-833. (Pubitemid 27072942)
90. Ventura J.E., M. Villa, R. Mizraji and R. Ferreiros. 1997. Acute renal failure in pregnancy. Ren. Fail. 19: 217-220. (Pubitemid 27147227)
91. Watson A.R. 1994. Urinary tract infection in early childhood. J. Antimicrob. Chemother. 34 Suppl A: 53-60.
92. Westerlund B., P. Kuusela, J. Risteli, L. Risteli, T. Vartio, H. Rauvala, R. Virkola and T.K. Korhonen. 1989. The O75X adhesin of uropathogenic Escherichia coli is a type IV collagen-binding protein. Mol. Microbiol. 3: 329-337. (Pubitemid 19104814)
93. White D.G. and P.F. McDrmott. 2001. Biocides, drug resistance and microbial evolution. Curr. Opin. Microbiol. 4: 313-317. (Pubitemid 32505989)
94. Wright K.J. and S.J. Hultgren. 2006. Sticky fibers and uropathogenesis: bacterial adhesins in the urinary tract. Future Microbiol. 1: 75-87.
95. Wyszyńska T. 1994. Urinary tract infections in children (in Polish). Klin. Pediatr. 2: 17-24.
96. Yamamoto S. 2007. Molecular epidemiology of uropathogenic Esche richia coli. J. Infect. Chemother. 13: 68-73. (Pubitemid 46669299)
97. Zafriri D., I. Ofek, R. Adar, M. Pocino and N. Sharon. 1989. Inhibitory activity of cranberry juice on adherence of type 1 and type#P fimbriated Escherichia coli to eucaryotic cells. Antimicrob. Agents Chemother. 33: 92-98. (Pubitemid 19015772)
98. Zavialov A.V., N.V. Batchikova, P. Korpela, L.E. Petrovskaya, V.G. Korobko, J. Kersley, S. MacIntyre and V.P. Zav'yalov. 2001. Secretion of recombinant proteins via the chaperone/usher pathway in Escherichia coli. Appl. Environ. Microbiol. 67: 1805-1814. (Pubitemid 33644954)
99. Zavialov A.V., J. Kersley, T. Korpela, V.P. Zav'yalov, S. MacIntyre and S.D. Knight. 2002. Donor strand complementation mechanism in the biogenesis of non-pilus systems. Mol. Microbiol. 45: 983-995. (Pubitemid 35007442)
100. Zavialov A.V., J. Berglund, A.F. Pudney, L.J. Fooks, T.M. Ibrahim, S. MacIntyre and S.D. Knight. 2003. Structure and biogenesis of the capsular F1 antigen from Yersinia pestis: preserved folding energy drives fiber formation. Cell 113: 587-596. (Pubitemid 36694184)
101. Zavialov A.V., V.M. Tischenko, L.J. Fooks, B.O. Brandsdal, J. Aqvist, V.P. Zav'yalov, S. Macintyre and S.D. Knight. 2005. Resolving the energy paradox of chaperone/usher-mediated fibre assembly. Biochem. J. 389: 685-694. (Pubitemid 41117328)
102. Zavialov A., G. Zav'yalova, T. Korpela and V. Zav'yalov. 2007. FGL chaperone-assembled fimbrial polyadhesins: anti-immune armament of Gram-negative bacterial pathogens. FEMS Microbiol. Rev. 31: 478-514. (Pubitemid 46920253)
103. Zav'yalov V.P., G.A. Zav'yalova, A.I. Denesyuk, M. Gaestel and T. Korpela. 1995. Structural and functional homology between periplasmic bacterial molecular chaperones and small heat shock proteins. FEMS Immunol. Med. Microbiol. 11: 265-272.